Related Experiment Video

Updated: Jul 20, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Cardiovascular disease and risk of Alzheimer's disease

Caterina Rosano1, Anne B Newman

  • 1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA. Rosanoc@edc.pitt.edu

Neurological Research
|September 2, 2006
PubMed

Insights

Cardiovascular disease and its risk factors are linked to Alzheimer's disease incidence. This review explores the evidence, pathways, and clinical relevance of these associations.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Growing evidence suggests a link between cardiovascular health and Alzheimer's disease (AD).
  • Cardiovascular diseases (CVD) share common risk factors with AD.
  • Understanding this relationship is crucial for public health.

Purpose of the Study:

  • To review the current evidence associating cardiovascular disease and its risk factors with Alzheimer's disease.
  • To explore potential pathogenetic mechanisms underlying these associations.
  • To discuss the clinical relevance and implications of these findings.

Main Methods:

  • Comprehensive literature search of recent studies.
  • Analysis of epidemiological data and clinical trial results.
  • Synthesis of evidence on shared risk factors and biological pathways.

Main Results:

  • Significant associations found between various cardiovascular conditions (e.g., hypertension, hyperlipidemia) and increased AD risk.
  • Evidence supports shared pathophysiological mechanisms, including vascular damage, inflammation, and metabolic dysfunction.
  • The review highlights the clinical importance of managing cardiovascular health to potentially mitigate AD risk.

Conclusions:

  • Cardiovascular disease and Alzheimer's disease are interconnected through shared risk factors and pathways.
  • Managing cardiovascular health may be a viable strategy for AD prevention or delay.
  • Further research is warranted to elucidate causal links and therapeutic targets.

More Related Videos

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...